Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	204	91	115	133	142	210
Market Cap Growth	86.29%	-21.18%	-13.63%	-6.58%	-32.20%	66.16%
Enterprise Value	191	99	121	129	124	180
Last Close Price	2.63	1.40	1.89	2.48	2.70	3.50
Forward PE	-	106.87	-	-	-	-
PS Ratio	27.29	12.31	8.10	8.48	13.42	22.07
PB Ratio	1.78	1.04	1.41	1.83	2.00	2.77
P/TBV Ratio	1.79	1.04	1.41	1.85	2.02	2.78
EV/Sales Ratio	25.55	13.40	8.53	8.19	11.66	18.92
Debt / Equity Ratio	0.16	0.19	0.22	0.31	0.25	0.18
Asset Turnover	0.06	0.07	0.14	0.16	0.11	0.11
Inventory Turnover	42.35	67.11	30.80	8.17	3.55	1.74
Quick Ratio	2.62	0.74	0.87	1.34	3.75	5.47
Current Ratio	2.62	0.75	0.87	1.34	3.76	5.51
Return on Equity (ROE)	-4.20%	-4.34%	-4.35%	-5.88%	-6.37%	-4.96%
Return on Assets (ROA)	-2.52%	-2.61%	-2.71%	-3.45%	-4.63%	-3.08%
Return on Capital (ROIC)	-2.65%	-2.77%	-2.92%	-3.74%	-4.92%	-3.27%
Earnings Yield	-2.07%	-4.05%	-2.92%	-3.18%	-3.29%	-1.62%
FCF Yield	-	-6.28%	-0.50%	-1.44%	-2.67%	-2.37%
Buyback Yield / Dilution	-23.15%	-6.35%	-10.10%	-4.80%	-	-15.99%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.